O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+5.97%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.28B
AUM Growth
+$8.28B
(+5.4%)
Cap. Flow
+$285M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
35.4%
Holding
137
New
11
Increased
41
Reduced
26
Closed
12
Top Buys
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$120M |
| 2 |
CELG
Celgene Corp
CELG
|
$110M |
| 3 |
SHPG
Shire pic
SHPG
|
$74.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
$73.6M |
| 5 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
$60.8M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$156M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$123M |
| 3 |
Prothena Corp
PRTA
|
$72.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$60M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$57.6M |
Sector Composition
| 1 | Healthcare | 84.96% |
| 2 | Financials | 0.08% |
| 3 | Technology | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
1
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $391M | 4.59% | 1,656,258 -78,676 | -5% | -$18.6M |
|
2
Bristol-Myers Squibb
BMY
$96B
| $349M | 4.09% | 7,189,000 +1,222,600 | +20% | +$59.3M |
|
3
Biogen
BIIB
$19.4B
| $342M | 4.01% | 1,084,200 +23,500 | +2% | +$7.41M |
|
4
AbbVie
ABBV
$372B
| $294M | 3.45% | 5,204,200 +410,400 | +9% | +$23.2M |
|
|
5
Gilead Sciences
GILD
$140B
| $285M | 3.34% | 3,434,800 -1,880,000 | -35% | -$156M |
|
6
Amgen
AMGN
$155B
| $266M | 3.12% | 2,245,000 -70,900 | -3% | -$8.39M |
|
|
AGN
7
DELISTED
ALLERGAN INC
AGN
| $261M | 3.07% | 1,543,700 -726,300 | -32% | -$123M |
|
8
HCA Healthcare
HCA
$94.5B
| $254M | 2.99% | 4,513,000 +298,000 | +7% | +$16.8M |
|
9
Illumina
ILMN
$15.8B
| $247M | 2.91% | 1,386,000 +25,500 | +2% | +$4.55M |
|
|
RLYP
10
DELISTED
RELYPSA INC COM
RLYP
| $242M | 2.84% | 9,941,551 | – | – |
|
|
ITMN
11
DELISTED
INTERMUNE INC
ITMN
| $240M | 2.81% | 5,425,200 -526,800 | -9% | -$23.3M |
|
|
CELG
12
DELISTED
Celgene Corp
CELG
| $228M | 2.68% | 2,655,000 +1,283,600 | +94% | +$110M |
|
|
SHPG
13
DELISTED
Shire pic
SHPG
| $213M | 2.5% | 905,200 +318,200 | +54% | +$74.9M |
|
14
Viatris
VTRS
$12.3B
| $204M | 2.39% | 3,952,700 +47,200 | +1% | +$2.43M |
|
15
Incyte
INCY
$16.5B
| $198M | 2.32% | 3,500,400 +376,400 | +12% | +$21.2M |
|
|
MDVN
16
DELISTED
MEDIVATION, INC.
MDVN
| $189M | 2.21% | 2,446,600 -277,500 | -10% | -$21.4M |
|
17
Thermo Fisher Scientific
TMO
$186B
| $181M | 2.13% | 1,535,700 +142,500 | +10% | +$16.8M |
|
18
Agilent Technologies
A
$35.7B
| $180M | 2.11% | 3,130,300 +87,700 | +3% | +$5.04M |
|
19
Perrigo
PRGO
$3.27B
| $172M | 2.02% | 1,181,700 +124,900 | +12% | +$18.2M |
|
|
CFN
20
DELISTED
CAREFUSION CORPORATION
CFN
| $163M | 1.91% | 3,671,000 +1,659,000 | +82% | +$73.6M |
|
|
IPXL
21
DELISTED
Impax Laboratories, Inc.
IPXL
| $162M | 1.91% | 5,415,600 +70,000 | +1% | +$2.1M |
|
22
Intuitive Surgical
ISRG
$170B
| $161M | 1.89% | 391,100 +54,800 | +16% | +$22.6M |
|
23
Merck
MRK
$210B
| $147M | 1.72% | 2,538,000 -9,000 | -0.4% | -$521K |
|
|
ESRX
24
DELISTED
Express Scripts Holding Company
ESRX
| $144M | 1.69% | 2,079,000 -18,000 | -0.9% | -$1.25M |
|
|
25
Ironwood Pharmaceuticals
IRWD
$214M
| $137M | 1.61% | 8,935,900 +7,853,800 | +726% | +$120M |
|